Viatris | VTRS - Vermögenswerte





Vermögenswerte Veränderung Datum
Celltrion KRW 779.18B 10.37B 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.28B 62.98M 2026-09
Divis Laboratories Ltd INR 219.64B 19.31B 2026-09
Kangmei Pharma CNY 13.07B 239.31M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 820.26M 298.95M 2026-06
Ovoca Bio EUR 2.07M 414K 2025-12
Pharma Mar EUR 408.4M 14.8M 2026-09
Qiagen NV USD 5.89B 107.14M 2026-06
Sartorius EUR 9.67B 70.9M 2026-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 34.68B 362M 2026-09
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 17.71B 799.05M 2026-09